The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Liver disease is a major health issue which present poor clinical treatment performance. Cirrhosis and liver failure are common clinical manifestations of liver diseases. Liver transplantation is recognized as the ultimate and most efficient therapy to the end stage of liver disease. But it was limited by the shortage of honor organs and high cost. Nowadays, stem cell therapy gained more and more attention due to its attractive efficacy in treating liver disease especially in cirrhosis during the clinical trials. Mesenchymal stem cell (MSC) can be differentiated into hepatocytes, promote liver regeneration, inhibit liver fibrosis and induce liver apoptosis, particularly via paracrine mechanisms. This review will highlight recent clinical applications of MSC, providing the available evidence and discussing some unsolved questions in treating liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819
Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., et al. (2005) · Nature Medicine · doi:10.1038/nm0405-367 · Cited by 1,677 · cited 1×
“CM contained paracrine soluble factors and extracellular vesicles (EVs) promoting tissue repair and regeneration (64).”
BackgroundMesenchymal Stem Cell Homing: The Devil Is in the Details
Karp, J. M., & Leng Teo, G. S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.02.001 · Cited by 1,445
Bernal, W., & Wendon, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208937 · Cited by 1,169
Zhang, Z., Lin, H., Shi, M., Xu, R., Fu, J., Lv, J., Chen, L., Lv, S., Li, Y., Yu, S., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07024.x · Cited by 372 · cited 2×
“In a 1-year follow-up clinical research, UC-MSC transplantation has been proved to be safe and could improve liver function and reduce ascites in patients with decompensated liver cirrhosis (39).”
BackgroundSuk, K. T., Yoon, J., Kim, M. Y., Kim, C. W., Kim, J. K., Park, H., Hwang, S. G., Kim, D. J., Lee, B. S., Lee, S. H., et al. (2016) · Hepatology · doi:10.1002/hep.28693 · Cited by 303 · cited 1×
“Autologous BM-MSCs were investigated to improve histologic fibrosis and liver function in patients with alcoholic cirrhosis (34,35).”
BackgroundLin, B., Chen, J., Qiu, W., Wang, K., Xie, D., Chen, X., Liu, Q., Peng, L., Li, J., Mei, Y., et al. (2017) · Hepatology · doi:10.1002/hep.29189 · Cited by 288 · cited 1×
“Comparing to control group, BM-MSCs effectively reduced the levels of ALT and ALB after 1 week of treatment (30).”
BackgroundPossamai, L. A., Thursz, M. R., Wendon, J. A., & Antoniades, C. G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.031 · Cited by 153
The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases
Liu, W., Song, F., Ren, L., Guo, W., Wang, T., Feng, Y., Tang, L., & Li, K. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12482 · Cited by 139
Liang, T., Zhu, L., Gao, W., Gong, M., Ren, J., Yao, H., Wang, K., & Shi, D. (2017) · FEBS Open Bio · doi:10.1002/2211-5463.12317 · Cited by 83 · cited 1×
“Direct coculture of endothelial progenitor cells (EPCs) and MSCs in vitro enhanced cell proliferation and angiogenic capacity, PDGF and Notch signaling pathways were involved in this effect (14).”
Background
Cited by
Psaraki, A., Ntari, L., Karakostas, C., Korrou‐Karava, D., & Roubelakis, M. G. (2022) · Hepatology · doi:10.1002/hep.32129 · Cited by 145
Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
Hu, C., Zhao, L., Zhang, L., Bao, Q., & Li, L. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01895-1 · Cited by 130
Self-citationMolecular pathways of liver regeneration: A comprehensive review
Kiseleva, Y. V., Antonyan, S. Z., Zharikova, T. S., Tupikin, K. A., Kalinin, D. V., & Zharikov, Y. O. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i3.270 · Cited by 62
Lu, W., Qu, J., Yan, L., Tang, X., Wang, X., Ye, A., Zou, Z., Li, L., Ye, J., & Zhou, L. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03518-x · Cited by 49
Self-citationMesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
Huang, W.-C., Li, Y.-C., Chen, P.-X., Ma, K. S.-K., & Wang, L.-T. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04127-y · Cited by 29
Metadata
- Authors
- Zhang, S., Yang, Y., Fan, L., Zhang, F., & Li, L.
- Venue
- Annals of Translational Medicine
- Publisher
- AME Publishing Company
- Published
- 2020-04
- Volume
- 8
- Issue
- 8
- Pages
- 565-565
- ISSN
- 2305-5839 (ISSN-L)
- 2305-5847
- OpenAlex
- W3022983691
- Cited by
- 56
- References
- 12
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future. https://app.cochat.ai/papers/10.21037/atm.2020.03.218
- The paper
- Zhang, S., Yang, Y., Fan, L., Zhang, F., & Li, L. (2020). The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future. Annals of Translational Medicine. https://doi.org/10.21037/atm.2020.03.218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.